Skip to main content
Log in

Melanoma cost burden high in Australia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 Australian dollars

Reference

  • Elliott TM, et al. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis. Applied Health Economics and Health Policy : 29 Jul 2017. Available from: URL: http://dx.doi.org/10.1007/s40258-017-0341-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Melanoma cost burden high in Australia. PharmacoEcon Outcomes News 784, 23 (2017). https://doi.org/10.1007/s40274-017-4234-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4234-y

Navigation